Schedule 13D ownership disclosure
Zomedica Pharmaceuticals Corp.
Security class unavailable · CUSIP: 98979F107
Event date: 2019-12-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 36.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-305862
- Form type
- SC 13D
- Filer
- Solensky Gerald JR
- CIK
- CIK 1721759
- Filed
- Dec 04, 2019
- Reporting period
- Dec 02, 2019
- Description
- Schedule 13D beneficial ownership